Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases.

Tas, Faruk; Duranyildiz, Derya; Oguz, Hilal; Camlica, Hakan; Yasasever, Vildan; Topuz, Erkan

Tas, Faruk; Duranyildiz, Derya; Oguz, Hilal; Camlica, Hakan; Yasasever, Vildan; Topuz, Erkan.

Affiliation

Tas F; Institute of Oncology, Istanbul University, Capa, 34390 Istanbul, Turkey. faruktas2002@yahoo.com

Med Oncol ; 25(3): 346-9, 2008.

Article in En | MEDLINE | ID: mdl-18204821

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Bone Neoplasms/secondary; Diphosphonates/therapeutic use; Fibroblast Growth Factor 2/blood; Imidazoles/therapeutic use; Vascular Endothelial Growth Factor A/blood; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors/administration & dosage; Bone Neoplasms/blood; Breast Neoplasms/blood; Breast Neoplasms/pathology; Diphosphonates/administration & dosage; Female; Humans; Imidazoles/administration & dosage; Lung Neoplasms/blood; Lung Neoplasms/pathology; Male; Middle Aged; Zoledronic Acid

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Neoplasms / Fibroblast Growth Factor 2 / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Diphosphonates / Imidazoles Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article

Fulltext

XML

PubMed Links

Search on Google